Latin American Journal of Pharmacy



 
 
 Vol. 35 N 1
Lat. Am. J. Pharm. 35 (1): 1-212 (2016)  


REGULAR ARTICLES
 
Determination of Simethicone Dry Suspension by IR  *
ZENG H., GAO M., ZHANG N., WU X., LUO X., LUO L. & LU Y.  (5)
 
 
Pharmacokinetic and Bioavailability Study of Ramelteon in Rat by Liquid Chromatography Mass Spectrometry  *
LIU Z., GENG P., HE Y., YANG S., ZHANG L., FAN Y., GU K., HU Y. & WEN C.  (11)
 
 
Hypoxia Exacerbates the Impairment of PIGF/JAK-STAT3 Signaling and Drug Metabolizing Enzymes in Preeclampsia  *
QU H., MU L., LIU H. & WANG X.  (17)
 
 
Antibiotic Knowledge and Willingness to Engage in Shared Decision-Making among Urban Children  *
ISLAHUDIN F., & LIM K.Y.  (26)
 
 
Ligustrazine -Loaded Stealth Liposomes: Cellular Uptake in Murine Phagocyte Cell Model and Pharmacokinetics in Rats  *
YANG Y., WANG Q., LI J., ZHAO Z. & LIU Y.  (32)
 
 
Ultra Performance Liquid Chromatography Tandem Mass Spectrometry Determination of Ibrutinib in Rat Plasma  *
CHEN X., WANG C., CHEN M., ZHOU Q., LIU Z., ZHANG J., ZHOU S., WEN C. & ZHANG M.  (38)
 
 
Bioavailability and Pharmacokinetic Study of Tirofiban in Rat by Liquid Chromatography Mass Spectrometry  *
YANG S., GENG P., LIN Y., ZHANG L., LIN Z., ZHANG M., YUAN Q., ZHANG K., XU H., WEN C. & ZHANG Z.  (44)
 
 
Development and Validation of a RP-HPLC Method for Simultaneous Determination of Metformin Hydrochloride, Phenol Red and Metoprolol Tartrate for Intestinal Perfusion Studies  *
GULSUN T. & SAHIN S.  (50)
 
 
Synthesis, Characterization and Cytotoxicity Evaluation of 5-Hydrazono-[1,2,4]triazolo[1,5- a]quinazolines (Part I)  *
AL-SALAHI R., ELSAYED E.A., EL DIB R.A., WADAAN M. , EZZELDIN E. & MARZOUK M.  (58)
 
 
Cytotoxicity of New 5-Hydrazono-[1,2,4]triazolo[1,5-a]quinazolines (Part II)  *
AL-SALAHI R., ELSAYED E.A., EL DIB R.A., WADAAN M., EZZELDIN E. & MARZOUK M.  (66)
 
 
Compound N-2 Attenuates Lipopolysaccharide-Induced Inflammation in RAW264.7 Macrophages and in Mice  *
LIU X., WANG X., WANG Y. & GONG G.  (74)
 
 
Early Stage of Drug Release Non-Classified in BCS Influenced By Coating Excipients: Hydroxypropyl Methylcellulose and Polyvinyl Alcohol  *
PADUSZYŃSKI P., KRUSIŃSKI T., HAN T. & MUSIAŁ W.  (84)
 
 
Neuroprotective Effects in PC12 Cells by Artemether, a Clinical Antimalarial Agent  *
ZHANG L., SUN Y., ZHANG L., GUO C., LI X., ZHANG C., WANG R. & CHEN H.  (91)
 
 
Hepatotoxicity, Acute Toxicity and Salmonella/Microsome Mutagenicity Assay (Ames) of Imatinib Microemulsions  *
BAŞPINAR Y., GUNDOGDU E., KOKSAL C., KARASULU H.Y., KARABAY YAVAŞOĞLU N.U. & KARASULU E.  (98)
 
 
Role of Topical and Systemic Therapy in Patients with Diabetic Foot Ulcer  *
HAO D., FENG G., CHU W., CHEN Z. & LI S.  (105)
 
 
Losartan Potassium Taste-masked Oral Disintegrating Tablets for Hypertensive Patients  *
SHAZLY G.A. & IBRAHIM M.A.  (110)
 
 
Determination of Ribavirin in Rat Plasma by UPLC-MS/MS: Application to a Pharmacokinetic Study  *
ZHANG R., ZHANG Y., ZHENG X., WANG B. & YOU J.  (118)
 
 
Development and Validation of a Reverse Phase HPLC Method for the Estimation of Lacidipine in Rat Plasma: Application to Preclinical Pharmacokinetics  *
SHIRODKAR R.K., KUMAR L., MISRA C., MANAGULI R., ATTARI Z., MUTALIK S. & LEWIS S.A.  (124)
 
 
A Simple HPLC Method for the Determination of Ibrutinib in Rabbit Plasma and its Application to a Pharmacokinetic Study  *
WEI L., XU Z., LV P., XUE Y., WANG X., & ZHANG M.  (130)
 
 
Determination of Voriconazole in Rat Plasma by UPLC-MS/MS and its Pharmacokinetic Study  *
WANG Q., LAI X., WANG H., SUN L. & SHAO M.  (135)
 
 
Pharmacokinetic Study of Colchicine in Rat Plasma by Ultra Performance Liquid Chromatography- Tandem Mass Spectrometry  *
WU M., SHEN H., YANG S., LIU Z., XU M., WEN C. & GAO G.  (140)
 
 
Comparative Drug Loading and Release Study on Some Carbohydrate Polymers  *
MASSEY S., IQBAL M.S., WOLF B., MARIAM I. & RAO S.  (146)
 
 
Noveon AA1 as a Matrix for Controlled Release of Direct Compression Tablets  *
ANGULO-DELGADO C.R. & VILLAFUERTE-ROBLES L.  (156)
 
 
Pharmacokinetic and Bioavailability Study of Azilsartan in Rat by LC-MS  *
LIN Y., GENG P., GAN Y., YANG S., LIU Z., XU M., WEN C. & LIN X.  (166)
 
 
Pharmacokinetics and Dosage Regimen of Danofloxacin by RP-HPLC/UV Method in Teddy Goats  *
MANZOOR Z. & IQBAL Z.  (172)
 
 
Comparison of Preparation Techniques and Characterization of Bfgf-p(Hb-ho) Nanoparticles  *
ZHANG Y., WANG Z., WU X., LV L. & ZHAO L.  (180)
 


SHORT COMMUNICATIONS
 
Podophyllotoxin-Induced Liver Toxicity Results in the Altered Metabolism of Anti-Glioma Drug Schisanhenol  *
WANG L., SHEN X., TIAN Y., JI P-, LIU J., WANG Z., TU Y. & ZHANG Y.  (187)
 
 
Cardiovascular Disease Treatment Drugs Gomisin G-Warfarin Interaction  *
GUO X. & HUANG C.  (192)
 
 
Mechanism Analysis for Clinical Lapatinib-Irinotecan Interaction  *
HAN J., YU J., JIANG Y., YU H., JIANG Y. & CAO Q.  (195)
 
 
Determination of Sorafenib in Rat Plasma Using HPLC and Application to a Pharmacokinetic Study  *
YANG L., LOU D., GE N., PAN Y., CHEN R. & YE J.  (201)
 
 
Cytotoxicity and Chemical Composition of the Essential Oils of Magnolia ovata  *
SCHARF D.R., SIMIONATTO E.L., MELLO-SILVA R., CARVALHO J.E., SALVADOR M.J. & STEFANELLO M..A.  (206)
 
 
Synthesis and Antitumor Activities of Two Novel Naphthol Derivatives  *
ZOU M., LU Y. & LI H.  (210)
 



_________________

* English

** Portugûes

 
LOG-IN                                 

User


Password




Forgot your password?






ACTIONS ___     ___ _         

Submit Article

Check Manuscript Status

Suscription

Free Sample Issue



STATISTICS ___     ___        

JCR Impact Factor 2014:
0.372

Issues per year: 10

ISSN 0326 2383 (printed ed.)

ISSN 2362-3853 (on line ed.)
 




© Latin American Journal of Pharmacy 2017 | All rights reserved

Developed by: CAFFINI / COMMUNICATION & DESIGN